VOLUME 60   1999   NUMBER 12

Brainstorms

813 Molecular Neurobiology for Practicing Psychiatrists, Part 4: Transferring the Message of Chemical Neurotransmission From Presynaptic Neurotransmitter to Postsynaptic Gene Expression. Stephen M. Stahl

Original Articles

815 Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients. Robert M. A. Hirschfeld, Michael H. Allen, Joseph P. McEvoy, Paul E. Keck, Jr., and James M. Russell
[Abstract]

819 The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation. Stefano Pallanti, Leonardo Quercioli, Alessandro Rossi, and Adolfo Pazzagli
[Abstract]

824 Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression. John P. Feighner and Kerstin Overø
[Abstract]

831 Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder. Abraham Bakker, Richard van Dyck, Philip Spinhoven, and Anton J. L. M. van Balkom
[Abstract]

839 Clinical Features, Psychiatric Comorbidity, and Health-Related Quality of Life in Persons Reporting Compulsive Computer Use Behavior. Donald W. Black, Geeta Belsare and Steven Schlosser
[Abstract]

845 Venlafaxine in the Treatment of Dysthymia: An Open-Label Study. David J. Hellerstein, Sarai T. Batchelder, Suzanne A. S. Little, Michael J. Fedak, David Kreditor, and Jesse Rosenthal
[Abstract]

850 Effectiveness of Antipsychotic Therapy in a Naturalistic Setting: A Comparison Between Risperidone, Perphenazine, and Haloperidol. Kim C. Coley, Cameron S. Carter, Stacey V. DaPos, RaeAnn Maxwell, John W. Wilson, and Robert A. Branch
[Abstract]

857 Buspirone as an Antidote to SSRI-Induced Bruxism in 4 Cases. John Michael Bostwick and Michael S. Jaffee
[Abstract]

861 Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate. Linda Franchini, Raffaella Zanardi, Mariangela Gasperini, and Enrico Smeraldi.
[Abstract]

CME Activity 873

874 Schizoaffective Disorder: A Form of Schizophrenia or Affective Disorder? Jovier D. Evans, Robert K. Heaton, Jane S. Paulsen, Lou Ann McAdams, Shelley C. Heaton, and Dilip V. Jeste
[Abstract]

Letters to the Editor

866 Sildenafil Treatment of Antidepressant-Induced Sexual Dysfunction. Timothy R. Berigan

Reply by Adam Keller Ashton

866 Improved Outcome in Fluvoxamine-Treated Patients With SSRI-Induced Sexual Dysfunction. Michael D. Banov

Reply by Anne N. Nafziger, Joseph S. Bertino, Jr., Angelica I. Goss-Bley, and Angela D. M. Kashuba

868 Choreiform Dyskinesia With Acute Onset and Protracted Course Following Fluoxetine Treatment. Asker Stig Nielsen and Ole Mors

869 Deliberate Self-Poisoning Following Fluvoxamine-Neuroleptics Combination. Siow-Ann Chong and Andrew Cheong

869 Penile Anesthesia Associated With Sertraline Use. Eberhard A. Deisenhammer and Rudolf Trawöger

870 Tardive Dyskinesia Associated With Olanzapine Monotherapy. Jambur Ananth and Joseph Kenan

Book Reviews 871

Subject Index 885

Author Index 898

Information for authors

see July 1999, pages 502-503 or our Web site at www.psychiatrist.com/author.htm

LETTERS TO THE EDITOR